Assistant Professor of Health Outcomes
Dr. Hyeun Ah Kang is an Assistant Professor in the Health Outcomes Division at The University of Texas at Austin (UT Austin) College of Pharmacy. Her research focuses on evaluating the impacts of health policies on health outcomes, healthcare resource utilization, costs, and identifying predictors of clinical and economic outcomes through the analysis of large real-world databases. Her areas of interest include health inequity, sickle cell disease, opioid use, and cancer disparities.
Dr. Kang has received several merit awards, including the 2023-2024 Provost Mentored Faculty Scholars Program – Mentee Cohort at UT Austin, the 2021-2022 American Association of Colleges of Pharmacy (AACP) New Investigator Award, and Best Student Poster Research Presentation at the 2018 and 2019 ISPOR Annual International Meetings. She was also recognized with the 2019 APhA Academy of Pharmaceutical Research and Science (APRS) Presentation Award and was an Abstract Award Winner in the Graduate Program at the UT Austin College of Pharmacy's 15th Annual Louis C. Littlefield Celebrating Pharmacy Research Excellence Day (2019).
Dr. Kang teaches courses on pharmacoeconomics, advanced research methods, and data analysis. She earned her Bachelor’s and Master’s degrees in Pharmacy in South Korea in 2009 and 2011, respectively, and worked as a researcher for the Health Insurance Review & Assessment Service (HIRA) in South Korea. She later obtained an M.Ed. in Quantitative Methods from UT Austin College of Education and a Ph.D. in Health Outcomes from UT Austin College of Pharmacy in 2017 and 2019, respectively. She is also the co-winner of the 2019 TxCORE Outstanding Graduate Student Award. Before joining UT Austin, she was a faculty member at The University of Texas at El Paso School of Pharmacy from 2019 to 2021.
Education
Ph.D., The University of Texas at Austin
M.Ed., The University of Texas at Austin
M.Pharm, Sookmyung Women’s University
B.Pharm, Sookmyung Women’s University
Research Profile
ORCid: https://orcid.org/0000-0003-1194-742X
Google Scholar: https://scholar.google.com/citations?hl=en&user=7396VV8AAAAJ
LinkedIn: https://www.linkedin.com/in/hyeun-ah-kang/
Selected Recent Publications
*Denotes student(s)/trainee(s) at the time of the study.
CORE Research Area: Patient-Centered Outcomes Research
Kang HA, Wang B, Barner JC, Ataga KI, Mignacca RC, Chang A, and Zhang Y. Opioid Prescribing and Outcomes in Patients with Sickle Cell Disease Post–2016 CDC Guideline. JAMA Internal Medicine. 2024;184(5):510-518. DOI:10.1001/jamainternmed.2023.8538
Kang HA and Barner JC. The relationship between out-of-pocket healthcare expenditures and insurance status among individuals with chronic obstructive pulmonary disease. Journal of Pharmaceutical Health Services Research. 2017;8(2):107-113. Doi: 10.1111/jphs.12170.
CORE Research Area: Healthcare Systems Research
Kang HA, Lee S, Park C, and Kim DS. Prevalence and predictors of non-steroidal anti-inflammatory drug/analgesic therapeutic duplication in the South Korean ambulatory care setting. European Journal of Clinical Pharmacology. 2016;72(1):109-116. doi: 10.1007/s00228-015-1958-0.
Kim DS, Je NK, Kim GJ, Kang HA, Kim YJ, and Lee S. Therapeutic duplicate prescribing in Korean ambulatory care settings using the National Health Insurance claim data. International Journal of Clinical Pharmacy. 2015;37(1):76-85. doi: 10.1007/s11096-014-0042-7.
CORE Research Area: Health Economics and Outcomes Research
Kang HA, Barner JC, Lawson KA, Rascati KL, and Mignacca RC. Association between higher hydroxyurea adherence and improved clinical and economic health outcomes among individuals with sickle cell disease. American Journal of Hematology. 2023;98:90–101.
Kang HA, Barner JC. The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease. Journal of Managed Care & Specialty Pharmacy. 2020;26(11):1412-1422. doi: 10.18553/jmcp.2020.26.11.1412.
Kang HA, Barner JC, Richards K, Bhor M, Paulose J, Kutlar A. Association between vaso-occlusive crises and opioid prescriptions among patients with sickle cell disease: A retrospective claims-based study. Journal of Health Economics and Outcomes Research. 2020; 7(1):94-101. doi: 10.36469/jheor.2020.13348.
Barner JC, Petrilla AA, Kang HA, Shen X, Alshehri AM, Sullivan E, Troeger KA, Richards KM, and Blackwell SC. Fetal fibronectin testing and pregnancy outcomes among Texas Medicaid patients at risk for preterm birth. The American Journal of Managed Care. 2017;23(19 Suppl):S363-S370.
Graduate Courses
- PGS 393T Pharmacoeconomics (Topic: Budget Impact Analysis, Pharmacy Services, International Perspectives, and Future Issues in Pharmacoeconomics)
- PGS 390U Advanced Research Methods (Topic: Propensity Scoring)
- PGS W390J Data Analysis in Health Care (Topic: SAS, SAS SQL)
PharmD Courses
- PHM 393F Pharmacoeconomics/Pharmacy Management (Topic: Cost-Effectiveness Analysis [CEA], Cost-Utility Analysis [CUA], and Health-Related Quality of Life [HRQoL])